Relationship between CHADS2 score and complex aortic plaques by transesophageal echocardiography in patients with nonvalvular atrial fibrillation
Related Experiment Video
Updated: Apr 27, 2026

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Kenichi Sugioka1, Suwako Fujita1, Shinichi Iwata1
1Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
Insights
The CHADS2 score predicts thromboembolism risk in non-valvular atrial fibrillation (NVAF). Higher CHADS2 scores correlate with complex aortic plaques, explaining some of the increased stroke risk in NVAF patients.
Area of Science:
- Cardiovascular Medicine
- Medical Imaging
- Thrombosis Research
Background:
- The CHADS2 score is a standard tool for assessing thromboembolic risk in non-valvular atrial fibrillation (NVAF).
- Previous research linked CHADS2 scores to left atrial abnormalities, but the association with complex aortic plaque, another thromboembolism risk factor, remains underexplored.
Purpose of the Study:
- To investigate the relationship between the CHADS2 score and the presence of complex aortic plaques in patients with NVAF.
- To determine if CHADS2 score independently predicts complex aortic plaque formation in this patient cohort.
Main Methods:
- Transesophageal echocardiography (TEE) was used to assess aortic plaques in 150 NVAF patients aged 55 years or older.
- Statistical analyses, including multivariate analysis, were performed to evaluate the association between CHADS2 score, atherosclerotic risk factors, left atrial abnormality, and complex aortic plaques.
Main Results:
- A significant positive correlation was observed between increasing CHADS2 scores and the prevalence of complex aortic plaques (p = 0.001).
- Multivariate analysis revealed that a CHADS2 score of 2 or higher was an independent predictor of complex aortic plaques (OR 3.39; 95% CI, 1.29-8.90), even after accounting for other risk factors.
Conclusions:
- Elevated CHADS2 scores are strongly associated with the presence of complex aortic plaques in NVAF patients.
- This association may partially elucidate the mechanism behind the heightened thromboembolic risk observed in NVAF patients with high CHADS2 scores.
Abstract:
The CHADS2 score is widely used for risk stratification of thromboembolism in patients with non-valvular atrial fibrillation (NVAF). Although the correlation of CHADS2 score with left atrial (LA) abnormality as detected by transesophageal echocardiography (TEE) has been reported in previous studies, the relationship between CHADS2 score and complex aortic plaque, which is also a significant risk factor for thromboembolism, has not been fully investigated. We assessed aortic plaques by TEE in 150 patients age ≥ 55 y with NVAF. The prevalence of complex aortic plaques increased along with increases in CHADS2 score (p = 0.001). In a multivariate analysis that included atherosclerotic risk factors and LA abnormality, a CHADS2 score ≥2 was independently associated with the presence of complex aortic plaques (odds ratio [OR] 3.39; 95% confidence interval [CI], 1.29-8.90). A high CHADS2 score is closely associated with the presence of complex aortic plaques, which explains, in part, the increased risk of thromboembolism in NVAF patients with high CHADS2 score.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Acute Coronary Syndrome III: Diagnostic Studies

